COVID-19 often goes undiagnosed in hospital workers; virus may impair heart functions

By Nancy Lapid

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

COVID-19 often undiagnosed in front line hospital workers

A high proportion of COVID-19 infections among U.S. healthcare personnel appear to go undetected, according to a report on Monday in the Morbidity and Mortality Weekly Report of the U.S. Centers for Disease Control and Prevention. Between April and June, among more than 3,000 front line workers in 12 states, roughly 1 in 20 had antibody evidence of a previous COVID-19 infection, but 69% of those infections had never been diagnosed. Among those with antibodies to the novel coronavirus, about one-third did not recall having symptoms in the preceding months, nearly half did not suspect that they had been infected, and some two-thirds had never had a positive COVID-19 test. Infections among front line healthcare personnel may be going undetected, the study authors say, because some infections may be only minimally symptomatic or asymptomatic and also because personnel with symptoms may not always have access to testing. COVID-19 antibodies were less common among workers who reported using a face covering for all patient encounters and more common among those who reported a shortage of personal protective equipment. The researchers call for more frequent testing of healthcare personnel and universal use of face coverings in hospitals.

Virus may impair heart’s beating, contracting

Following recent reports that the new coronavirus can invade heart muscle cells comes the discovery that infected cells show impairments in function. In test tube experiments, researchers infected “myocytes,” or heart muscle cells, with the new coronavirus and found that before the infected cells die, they progressively lose their “electrophysiological and contractile properties.” This means they have trouble transmitting the electrical impulses that regulate heartbeats and shortening or lengthening their fibers so the heart can expand and contract to pump blood. In a paper posted online Sunday on bioRxiv ahead of peer review, the researchers note that their test tube experiments likely do not exactly replicate what happens with cells in the body, and more research is needed to confirm their findings. Still, they say, their results suggest that cardiac symptoms in COVID-19 patients are likely a direct effect of the virus and warn that “long-term cardiac complications might be possible … in patients who recover from this illness.”

Eye symptoms common in children with COVID-19

Children with COVID-19 often have non-serious eye symptoms like itching, discharge, or pink eye, a study from China suggests. Among 216 children hospitalized with COVID-19 in Wuhan, the epicenter of the outbreak there, 23% had these kinds of eye issues, doctors found. Eye problems were more common in children with other symptoms such as cough or fever. In all cases, the eye problems were mild and eventually went away either without treatment or with “minimal” eye drops, researchers reported in JAMA Ophthalmology. It is reassuring that most of the children had other symptoms first, said Dr. Douglas Fredrick, chief of pediatric ophthalmology at the Mount Sinai Health system in New York City, who was not involved in the study. If conjunctivitis, or pink eye, were always among the first symptoms, “we’d be more worried that children could spread this by pink eye from one child to another,” he told Reuters. Still, he said, the study doesn’t completely rule out that type of transmission.

Cell phone activity may predict COVID-19 spread

Cell phone use patterns suggest that when people stay home, coronavirus infection rates go down, researchers say. For a study published on Monday in JAMA Internal Medicine, they analyzed publicly available de-identified cell phone activity and location data collected between January and May from 2,740 counties across the United States. After mid-February, when the coronavirus outbreak began, cell phone activity declined significantly in workplaces, stores and restaurants, and mass transit stations and increased in homes – with the greatest initial changes seen in areas with higher rates of COVID-19. Two weeks after cell phone activity shifted away from workplaces and retail locations, the counties with the most pronounced changes had the lowest rates of new COVID-19 cases. “Perhaps reassuringly,” the researchers said, cell phone activity at grocery stores and in areas classified as parks was not strongly associated with rates of growth in COVID-19 cases. They speculate that publicly available cell phone location data might help health offices better predict COVID-19 growth rates and inform decision about where to implement shutdowns and re-openings.

(Reporting by Nancy Lapid and Linda Carroll; Editing by Bill Berkrot)

U.S. COVID-19 deaths exceed 180,000, cases continue to fall

By Lisa Shumaker

(Reuters) – U.S. deaths from the novel coronavirus topped 180,000 on Thursday after a surge of new cases in June and July, many of them in hotspots like California, Florida, and Texas.

There were some signs of an improving outlook. Last week, deaths fell 17% from the prior week and below an average of 1,000 a day for the first time in weeks, according to a Reuters analysis.

However, while U.S. metrics on cases, deaths, hospitalizations and test positivity rates were declining, health experts warned there could be another surge as schools reopen and colder weather forces more gatherings indoors.

This week, the U.S. Centers for Disease Control and Prevention (CDC) said people exposed to COVID-19 but not symptomatic may not need to be tested. This contradicted earlier guidance from the CDC, shocking doctors and politicians and prompting accusations that it may have been based not on sound science but on political pressure from the Trump administration.

The governors of New York, New Jersey and Connecticut slammed the CDC’s move as “reckless” and “not based on science,” and said they will not change testing guidelines in their states.

“CDC and HHS have not shared their scientific rationale for this change in policy, which substitutes sound science-based public health guidance with the president’s misinformation,” they said in a joint statement. “Health experts recommend testing close contacts of individuals with COVID-19 to identify and prevent asymptomatic spread. This type of robust testing by our states has been a key factor in our success so far to flatten the curve in the tri-state area.”

On Wednesday, the top U.S. government infectious disease expert Anthony Fauci told CNN he was having surgery during discussion of the change and expressed worry about the CDC’s move.

U.S. confirmed cases are now over 5.8 million – the highest total in the world. The U.S. death toll is also the world’s highest.

On a per capita basis, the United States ranks 12th in the world for the number of deaths, with 54 deaths per 100,000 people, and tenth in the world for cases, with 1,774 cases per 100,000 residents, according to a Reuters analysis.

U.S. consumer confidence dropped in August to its lowest in more than six years, as households worried about the labor market and incomes, casting doubts on the sustainability of the economy’s recovery from the COVID-19 recession.

The ebb in confidence followed the expiration of a $600 weekly unemployment benefit supplement on July 31.

For weeks, Republicans and Democrats have been deadlocked over the size and shape of a fifth coronavirus-response bill, on top of the approximately $3 trillion already enacted into law.

(Reporting by Lisa Shumaker, additional reporting by Maria Caspani, Editing by Rosalba O’Brien and David Gregorio)

U.S. CDC reports 177,759 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday said the number of deaths due to the coronavirus had risen by 1,142 to 177,759 and also reported 5,752,653 cases, an increase of 37,086 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Aug. 25 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru, Editing by Sherry Jacob-Phillips)

Moderna’s COVID-19 vaccine shows similar immune response in old and young

(Reuters) – Moderna Inc said on Wednesday that an analysis of the early-stage data of its experimental COVID-19 vaccine showed it induced immune responses in older adults that were similar to younger participants.

The drug developer is one of the leading U.S. contenders in the race to develop a safe and effective vaccine against the novel coronavirus and its candidate, mRNA-1273, is already in the Phase 3 stage of human testing.

Moderna is now reporting interim data from the Phase 1 study, which includes new analysis from 20 additional people and details on how the vaccine performs in older people.

The analysis looked at 100 micro gram dosage that has been selected for the larger Phase 3 trial. Moderna said the immune responses in those aged between 56 and 70 years, above 70 and those in the age-group of 18 and 55 were similar.

The data is being presented at the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices meeting on Wednesday.

The company has so far enrolled over 13,000 participants in the late-stage study and about 18% of the total participants are Black, Latino, American Indian or Alaska Native, groups that are the hardest hit by the pandemic.

Moderna, which has no drugs in the market, has received nearly $1 billion from the U.S. government under a plan to speed up vaccine development for COVID-19. It has also struck a $1.5 billion supply agreement with the United States.

Shares of the drug developer rose more than 7% to $71.35 after the data. They have more than tripled in value so far this year and results from its studies have boosted the broader market.

(Reporting by Manojna Maddipatla in Bengaluru; Additional reporting by Ankur Banerjee; Editing by Arun Koyyur)

U.S. CDC reports 173,490 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Friday said the number of deaths due to the new coronavirus had risen by 1,074 to 173,490 and reported 5,551,793 cases, an increase of 44,864 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Aug. 20 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath)

U.S. CDC reports 172,416 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Thursday said the number of deaths due to the new coronavirus had risen by 1,404 to 172,416 and reported 5,506,929 cases, an increase of 46,500 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Aug. 19 compared with its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting By Mrinalika Roy in Bengaluru; Editing by Devika Syamnath)

As U.S. schools reopen, concerns grow that kids spread coronavirus

By Deena Beasley

(Reuters) – U.S. students are returning to school in person and online in the middle of a pandemic, and the stakes for educators and families are rising in the face of emerging research that shows children could be a risk for spreading the new coronavirus.

Several large studies have shown that the vast majority of children who contract COVID-19, the disease caused by the virus, have milder illness than adults. And early reports did not find strong evidence of children as major contributors to the deadly virus that has killed more than 780,000 people globally.

But more recent studies are starting to show how contagious infected children, even those with no symptoms, might be.

“Contrary to what we believed, based on the epidemiological data, kids are not spared from this pandemic,” said Dr. Alessio Fasano, director of the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital and author of a new study.

Schools across the country are trying out a wide range of strategies to reopen, from all online classes to all in person. They are asking whether reopening schools with stringent mitigation measures is worth the risk to students, families and educators, given that keeping schools closed will likely harm academic progress, social and emotional development, mental health and food security.

Dr. Fasano and colleagues at Boston’s Massachusetts General and MassGeneral Hospital for Children found that infected children have a significantly higher level of virus in their airways than adults hospitalized in intensive care units for COVID-19 treatment. The high viral levels were found in infants through young adults, although most of the participants were age 11 to 17.

The study, published on Thursday in the Journal of Pediatrics, involved 192 participants ages 0-22 who were seen at urgent care clinics for suspected COVID-19. Forty-nine of them – a quarter of the total – tested positive for the virus. Another 18 were included in the study after being diagnosed with multi-system inflammatory syndrome, a serious COVID-related illness than can develop several weeks after an infection.

The research suggests that children can carry a high viral load, meaning they can be very contagious, regardless of their susceptibility to developing a COVID-19 illness.

“There has been some conflicting data out there about the degree to which children can be contagious,” said Dr. Marybeth Sexton, assistant professor of infectious diseases at Emory University School of Medicine in Atlanta, who was not involved in the study. “This is further evidence that we may see children as sources of infection.”

She added more extensive research is needed.

“NOBODY IS SPARED”

A separate study published last month in JAMA Pediatrics found that older children hospitalized with COVID-19 had similar levels of the virus in their upper respiratory tract as adults, but children younger than five carried significantly greater amounts.

However, other medical groups show differing information over children’s potential to spread the virus. The American Academy of Pediatrics on Wednesday updated its guidelines to reflect “that children under 10 years may be less likely to become infected and spread infection, while those 10 years and older may spread it as efficiently as adults.”

A recent South Korean study found that people were most likely to contract the new coronavirus from members of their own households, with children aged nine and under least likely to be the first identified case.

Since most children infected with the coronavirus have very mild symptoms, they were largely overlooked as a demographic in the earlier stages of the pandemic, Dr. Fasano said.

The U.S. Centers for Disease Control and Prevention reported a pediatric COVID-19 hospitalization rate of 8 per 100,000 for March 1 to July 25, compared with a rate of 164.5 per 100,000 for adults.

Experts say the incidence of a related issue, which can develop after COVID-19 infection, multi-system inflammatory syndrome, is concerning. “The number of these patients is growing,” Dr. Fasano added.

Concerns have also been raised about cases of type 1 diabetes among children diagnosed with COVID-19. A small UK study found that the rate of diabetes almost doubled during the peak of Britain’s COVID-19 epidemic, suggesting a possible link between the two diseases that needs more investigation.

“The more we understand, the more it boils down to nobody is spared in this pandemic,” Dr. Fasano said.

(Reporting By Deena Beasley; Editing by Peter Henderson and Aurora Ellis)

U.S. CDC reports 171,012 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday said the number of deaths due to the new coronavirus had risen by 1,172 to 171,012 and reported 5,460,429 cases, an increase of 39,318 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Aug. 18 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath)

U.S. CDC reports 169,870 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday said the number of deaths due to the new coronavirus had risen by 520 to 169,870 and reported 5,422,242 cases, an increase of 40,117 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Aug. 17 compared with its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Vinay Dwivedi)

U.S. CDC reports 169,350 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Monday said the number of deaths due to the new coronavirus had risen by 654 to 169,350 and reported 5,382,125 cases, an increase of 41,893 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on August 16 versus its previous report released on Sunday.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Manas Mishra in Bengaluru; Editing by Devika Syamnath)